ETEVRITAMAB

Approval Year

Substance Class	Protein Created by `admin` on `Sat Dec 16 14:17:49 GMT 2023` Edited by `admin` on `Sat Dec 16 14:17:49 GMT 2023`
Protein Type	BISPECIFIC ANTIBODY
Protein Sub Type	BISPECIFIC T CELL ENGAGER
Sequence Origin	HUMAN
Sequence Type	COMPLETE
Record UNII	WR4J8FV2SM
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

ETEVRITAMAB

Official Name

English

ANTI-EGFRVIII/CD3 BITE ANTIBODY AMG 596

Common Name

English

IMMUNOGLOBULIN, BISPECIFIC, ANTI-(HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR VARIANT III) (HUMAN MONOCLONAL EGFRVIII BISPECIFIC 1 SINGLE-CHAIN VARIABLE FRAGMENT VH1-(GGGGS)3-VL1) FUSION PROTEIN WITH PEPTIDE LINKER (GGGGS) FUSION PROTEIN WITH IMMUNOGLOBULIN A

Common Name

English

AMG596

Code

English

AMG-596

Code

English

etevritamab [INN]

Common Name

English

IMMUNOGLOBULIN SCFV-SCFV, ANTI-(HOMO SAPIENS EGFR (EPIDERMAL GROWTH FACTOR RECEPTOR, RECEPTOR TYROSINE-PROTEIN KINASE ERBB-1, ERBB1, HER1, HER-1, ERBB) VARIANT III (EGFRVIII)) AND ANTI-(HOMO SAPIENS CD3E (CD3 EPSILON, LEU-4)), MONOCLONAL ANTIBODY SINGLE

Common Name

English

Classification Tree Code System Code

FDA ORPHAN DRUG

634718